Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Application of repetitive transcranial magnetic stimulation was effective and safe in treating a 55-year-old man with comorbid depression and panic disorder, which occurred 6 months after a myocardial infarction.
Sakkas
Pavlos
P
Athens University Medical School, Psychiatry Department, Eginitio Hospital, 74 Vas. Sofias Avenue, Athens 11528, Greece. psakkas@cc.uoa.gr
Psarros
Constantin
C
Papadimitriou
George N
GN
Theleritis
Christos G
CG
Soldatos
Constantin R
CR
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000523:psychology*; D016584:Panic Disorder / Q000150:complications* / Q000209:etiology / Q000628:therapy*; D011569:Psychiatric Status Rating Scales; D050781:Transcranial Magnetic Stimulation; D000069470:Venlafaxine Hydrochloride
D014151:Anti-Anxiety Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D015283:Citalopram; D003009:Clorazepate Dipotassium; D000069470:Venlafaxine Hydrochloride